Evaluation of Microvascular Injury in Revascularized Patients With ST-Segment–Elevation Myocardial Infarction Treated With Ticagrelor Versus Prasugrel
Author(s) -
Maarten A.H. van Leeuwen,
Nina W. van der Hoeven,
Gladys N. Janssens,
Henk Everaars,
Alexander Nap,
Jorrit S. Lemkes,
Guus A. de Waard,
Peter M. van de Ven,
Albert C. van Rossum,
Tim J.F. ten Cate,
Jan J. Piek,
Clemens von Birgelen,
Javier Escaned,
Marco Valgimigli,
Roberto Diletti,
Niels P. Riksen,
Nicolas M. Van Mieghem,
Robin Nijveldt,
Niels van Royen
Publication year - 2019
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.118.035931
Subject(s) - ticagrelor , prasugrel , medicine , interquartile range , cardiology , myocardial infarction , percutaneous coronary intervention
Despite successful restoration of epicardial vessel patency with primary percutaneous coronary intervention, coronary microvascular injury occurs in a large proportion of patients with ST-segment-elevation myocardial infarction, adversely affecting clinical and functional outcome. Ticagrelor has been reported to increase plasma adenosine levels, which might have a protective effect on the microcirculation. We investigated whether ticagrelor maintenance therapy after revascularized ST-segment-elevation myocardial infarction is associated with less coronary microvascular injury compared to prasugrel maintenance therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom